الصفحة الرئيسيةBT3 • FRA
add
Lineage Cell Therapeutics Inc
سعر الإغلاق السابق
0.78 €
نطاق الأسعار خلال اليوم
0.78 € - 0.78 €
نطاق الأسعار في سنة
0.33 € - 1.00 €
رأس المال السوقي
215.78 مليون USD
متوسّط حجم التداول
106.00
نسبة P/E
-
عائد أرباح الأسهم
-
أخبار السوق
لمحة
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
تاريخ التأسيس
1990
الموقع الإلكتروني
عدد الموظفين
74